Phase I evaluation of docetaxel and topo
β
Anne S. Tsao; Dong M. Shin; J. Lynn Palmer; Jin S. Lee; Bonnie S. Glisson
π
Article
π
2004
π
John Wiley and Sons
π
English
β 79 KB
## Abstract ## BACKGROUND The authors administered a combination of docetaxel and topotecan with granulocyteβcolonyβstimulating factor (GβCSF) support in a Phase I study to define the maximum tolerated dose (MTD) of this regimen. ## METHODS Patients with advancedβstage solid tumors were eligible